<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04662515</url>
  </required_header>
  <id_info>
    <org_study_id>AK-BLD</org_study_id>
    <nct_id>NCT04662515</nct_id>
  </id_info>
  <brief_title>NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications</brief_title>
  <official_title>Novel Oral Anticoagulants in Oral and Maxillofacial Surgery: Impact on Bleeding Tendency, Surgical Difficulty and Post-operative Complications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Malmö University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Odontologisk Forskning i Region Skåne (OFRS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Malmö University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims: To investigate the incidence of bleeding complications during oral surgical procedures&#xD;
      in patients medicated with DOACs.&#xD;
&#xD;
      To investigate the perioperative and postoperative bleeding volume during oral surgical&#xD;
      procedures in patients medicated with DOACs.&#xD;
&#xD;
      To examine whether increased perioperative bleeding volume complicates the planned&#xD;
      intervention, thereby prolonging the operation time.&#xD;
&#xD;
      Previous studies have shown that the incidence of healthcare-consuming bleeding complications&#xD;
      following oral surgical procedures in patients who are prescribed warfarin is approximately&#xD;
      4% (9). To investigate whether the incidence is higher or lower by the intake of DOAC it is&#xD;
      considered to be sufficient with 100 patients in each group. The groups consist of patients&#xD;
      who are prescribed warfarin, DOACs, as well as a control group.&#xD;
&#xD;
      Hypothetical outcomes: The incidence of bleeding complications and the perioperative and&#xD;
      postoperative bleeding volume during oral surgical procedures in patients medicated with&#xD;
      DOACs are higher compared to patients medicated with warfarin and patients taking no&#xD;
      anticoagulants. Increased perioperative bleeding volume complicates the planned intervention,&#xD;
      thereby prolonging the operation time.&#xD;
&#xD;
      Clinical relevance: The study will serve as a basis for the development of treatment&#xD;
      guidelines for patients who medicate with DOACs. If it turns out that the oral surgery&#xD;
      procedure presents no increased risk of complications and that the bleeding volume does not&#xD;
      complicate the surgery significantly, it may be recommended that patients who medicate with&#xD;
      DOACs whom are in need of oral surgical procedures seek ordinary dental care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The continuous variables (amount of bleeding during surgery) will be analyzed with linear&#xD;
      regression if they show normal distribution patterns.&#xD;
&#xD;
      The ordinal variables (postoperative bleeding complications) will be analyzed with ordinal&#xD;
      logistic regression.&#xD;
&#xD;
      Dichotomous variables (presence of other postoperative complications) will be analyzed with&#xD;
      logistic regression.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>bleeding complication</measure>
    <time_frame>4 weeks postoperatively</time_frame>
    <description>proportion of patients who are in need of non planned/emergency medical or dental care after tooth extraction / oral surgery because of bleeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>bleeding volume</measure>
    <time_frame>the actual time of surgery</time_frame>
    <description>the amount of blood that the patient is bleeding during tooth extraction / oral surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>surgical difficulty</measure>
    <time_frame>the actual time of surgery</time_frame>
    <description>estimation on a scale of 1-10 by the surgeon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>surgery time in minutes</measure>
    <time_frame>the actual time of surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>proportion of other postoperative complications</measure>
    <time_frame>4 weeks postoperatively</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Surgery, Oral</condition>
  <condition>Hemorrhage</condition>
  <condition>Postoperative Complications</condition>
  <condition>Oral Surgical Procedures</condition>
  <condition>Anticoagulants Causing Adverse Effects in Therapeutic Use</condition>
  <condition>Anticoagulant-induced Bleeding</condition>
  <arm_group>
    <arm_group_label>DOAC</arm_group_label>
    <description>Information about which type of DOAC and the dose that is prescribed to the patient will be collected.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Warfarin</arm_group_label>
    <description>A PK-INR ≤3.0 retained whitin the last 24 hours have to be present for inclusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No blood thinners</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Type of surgery</intervention_name>
    <description>surgical or non-surgical extraction one or more teeth</description>
    <arm_group_label>DOAC</arm_group_label>
    <arm_group_label>No blood thinners</arm_group_label>
    <arm_group_label>Warfarin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dabigatran</intervention_name>
    <arm_group_label>DOAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivaroxaban</intervention_name>
    <arm_group_label>DOAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Apixaban</intervention_name>
    <arm_group_label>DOAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Edoxaban</intervention_name>
    <arm_group_label>DOAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Warfarin</intervention_name>
    <arm_group_label>Warfarin</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred to either the oral surgery department at Skåne University hospital or the&#xD;
        department for Oral surgery and oral medicine, Malmö University.&#xD;
&#xD;
        The plan is to ask all patients consecutively referred to the clinics for participation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Need of dental extraction / oral surgery, and medication with:&#xD;
&#xD;
          1. warfarin or&#xD;
&#xD;
          2. DOACs or&#xD;
&#xD;
          3. no treatment or AK-platelet therapy and age-matched to group a) and b).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Medication with the combination of anticoagulants and antiplatelet Ongoing drug abuse&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonas P becktor, DDS, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Odontology, Malmö University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Krister Johansson, DDS</last_name>
    <email>krister.johansson@mau.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Skåne University Hospital</name>
      <address>
        <city>Helsingborg</city>
        <zip>SE - 251 87</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reception Reception</last_name>
      <phone>004642-406 28 90</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Oral and Maxillofacial Surgery and Oral Medicine, Faculty of Odontology, Malmö University</name>
      <address>
        <city>Malmö</city>
        <zip>S-20506</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>service desk</last_name>
      <phone>040-665 70 00</phone>
      <email>info@mau.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>December 4, 2020</study_first_submitted>
  <study_first_submitted_qc>December 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2020</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Malmö University</investigator_affiliation>
    <investigator_full_name>Krister Johansson</investigator_full_name>
    <investigator_title>Dr Krister Johansson. Department of Oral and Maxillofacial Surgery and Oral Medicine, Faculty of Odontology, Malmö University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
    <mesh_term>Rivaroxaban</mesh_term>
    <mesh_term>Dabigatran</mesh_term>
    <mesh_term>Apixaban</mesh_term>
    <mesh_term>Edoxaban</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

